Spatio-temporal analysis of COVID-19 cases to inform scaling down of confinement measures as well as reactive strategies onward
A modelling analysis
- Durada
- 04/05/2020 - 31/08/2020
- Coordinador
- Carlos Chaccour
The COVID-19 pandemic has now spread to almost all countries around the world. The response in almost all countries in Europe has been to implement a series of “non-pharmaceutical interventions” (NPIs) – including a banning of mass gatherings, closure of schools and universities, and more general restrictions on populations movements including full lockdowns. In most countries, we now have evidence to show that these NPIs have significantly reduced transmission such that the reproductive number – the average number of new infections generated by each initial infection – is close to or just below the threshold value of 1 required to bring the epidemic under control (Flaxman et al. 2020). However, there remains considerable uncertainty as to how these measures can be relaxed in the coming weeks and months whilst ensuring there are no rebound epidemics.
One of the proposed methods for relaxing existing interventions is to restrict movements to a smaller subset of the population. Two approaches are possible, alone or in tandem:
- Restrict the movement of those at highest risk from severe disease – essentially shielding this population whilst allowing a degree of ongoing transmission in the lower risk population
- Using app-based technology, combined with rapid testing, to rapidly isolate cases and their contacts.
The detailed data collected by the Catalonian government provide the opportunity to better understand the impact of these two approaches.
Our Team
Coordinator
-
CARLOS CHACCOUR Assistant Research Professor. Coinvestigador principal i director científic del projecte BOHEMIA. Malària, Virus emergents
ISGlobal involved staff
-
SERGI SANZ Responsable de Departament - Estadística
-
Aina Casellas Torrentó
Altres projectes
Veure projectes passatsCOMBACTE
Combatent la Resistència Bacteriana a Europa
GAMA
Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting
Desenvolupament d'estratègies per a l'Eradicació de la Malaltia de Pian
Eradicació del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
MAMAH
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
INTE-AFRICA
Integrating and decentralizing diabetes and hypertension services in Africa
ICARIA
Improving Care through Azithromycin Research for Infants in Africa
PreFIT
Predicting the Future: Incipient Tuberculosis
Predicting the Future: Incipient Tuberculosis
Encuesta serológica Cendea de Cizur
Cendea de Cizur
Projecte de Recerca en Resposta Immunitària i Epidemiologia de Malalties Infeccioses
Conèixer la propagació. Entendre la protecció
ANTICOV
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Stool4TB
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
TB-RECONNECT
Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status
SToolNIH
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
ALIA - Las ciudades y la salud
Planificación urbana, medio ambiente y salud | Clima y salud | Resistencias Antimicrobianas
END-VOC
ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)
TwinAir
Digital Twins Enabled Indoor Air Quality Management for Healthy Living
Estudio de la propagación de bacterias y genes de resistencia a los antibióticos en el ciclo integral del agua, en el área metropolitana de Barcelona
Propagación de la resistencia en aguas
Nuevos complejos de oro (III) frente a bacterias multirresistentes
Project Code: DTS21/00004
Desarrollo de dos nuevas estrategias terapéuticas (inhibidores de bombas de expulsion y ARN antisentido) activos frente a bacterias mutliresistentes
Más allá de la supresión vírica del VIH: un cuarto noventa para mejorar la salud de personas viviendo con el VIH en España
Project Code: PI20/01654
ENDÈMIC
Community knowledge generation through scientific culture, urban ecology and art
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
Hepatitis C Free Baleares
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
FLAVOBAC
Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias